Chae Y S, Flotte T, Hsu D W, Preffer F, Hedley-Whyte E T
Department of Pathology (Neuropathology), Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
Gen Diagn Pathol. 1996 Oct;142(2):89-95.
Flow cytometric analysis was applied to embedded tissue to measure the proliferative activity and the DNA ploidy of 16 recurrent and 17 nonrecurrent pituitary adenomas. The results were compared with data from a previous study which demonstrated that proliferating cell nuclear antigen (PCNA) labeling index was higher in recurrent adenomas than in nonrecurrent adenomas. Flow cytometric analysis as a tool for predicting aggressive behavior has been useful in a variety of human tumors; however, its prognostic value in pituitary adenomas is controversial. Therefore, we decided to explore the relationship of the results of flow cytometry and proliferating cell nuclear antigen labeling indices with the prognosis of pituitary adenomas. Three out of 16 recurrent adenomas and five out of 17 nonrecurrent adenomas demonstrated a DNA aneuploid pattern. All the nonfunctional recurrent adenomas had a diploid pattern, while only 40% of the functional recurrent adenomas had a diploid pattern. The GO/G1 phase fraction was higher in the recurrent adenomas, than in the nonrecurrent ones (p = 0.0005). In contrast, the S-phase fraction and the coefficient of variation were higher in the nonrecurrent adenomas (5.9 +/- 1.0%, 7.0 +/- 0.75, respectively) than in the recurrent ones (2.5 +/- 0.6%, 4.0 +/- 0.2%, respectively) (p = 0.003 and p = 0.001, respectively). The proliferating cell nuclear antigen labeling indices were higher in the recurrent adenomas (18.9 +/- 4.5%) than in the nonrecurrent adenomas (2.6 +/- 1.6%) (p = 0.003). The S-phase of flow cytometry correlated weakly with the proliferating cell nuclear antigen labeling indices when the recurrent and the nonrecurrent adenomas were considered as one group. (r = -0.356, p = 0.033). But no significant correlations were observed when the groups of recurrent (r = -0.311, p = 0.195) and nonrecurrent tumors (r = -0.019, p = 0.942) were compared separately. The results of flow cytometric analysis suggest that recurrent adenomas may have a higher proportion of cells in the presynthetic phase than the nonrecurrent adenomas. This study suggests that flow cytometric analysis is of limited value in predicting recurrence of pituitary adenomas.
采用流式细胞术分析包埋组织,以测量16例复发性垂体腺瘤和17例非复发性垂体腺瘤的增殖活性及DNA倍体。将结果与之前一项研究的数据进行比较,该研究表明复发性腺瘤中增殖细胞核抗原(PCNA)标记指数高于非复发性腺瘤。流式细胞术作为预测侵袭性行为的工具,在多种人类肿瘤中已被证明是有用的;然而,其在垂体腺瘤中的预后价值仍存在争议。因此,我们决定探讨流式细胞术结果和增殖细胞核抗原标记指数与垂体腺瘤预后的关系。16例复发性腺瘤中有3例、17例非复发性腺瘤中有5例表现出DNA非整倍体模式。所有无功能复发性腺瘤均为二倍体模式,而只有40%的功能性复发性腺瘤为二倍体模式。复发性腺瘤的G0/G1期分数高于非复发性腺瘤(p = 0.0005)。相反,非复发性腺瘤的S期分数和变异系数(分别为5.9±1.0%、7.0±0.75)高于复发性腺瘤(分别为2.5±0.6%、4.0±0.2%)(p分别为0.003和0.001)。复发性腺瘤的增殖细胞核抗原标记指数(18.9±4.5%)高于非复发性腺瘤(2.6±1.6%)(p = 0.003)。当将复发性和非复发性腺瘤视为一组时,流式细胞术的S期与增殖细胞核抗原标记指数呈弱相关(r = -0.356,p = 0.033)。但分别比较复发性肿瘤组(r = -0.311,p = 0.195)和非复发性肿瘤组(r = -0.019,p = 0.942)时,未观察到显著相关性。流式细胞术分析结果表明,复发性腺瘤在合成前期的细胞比例可能高于非复发性腺瘤。本研究表明,流式细胞术分析在预测垂体腺瘤复发方面价值有限。